Nanoantibiotics Inc Stock Other OTC
Equities
US63009U1025
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 26.62M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.48
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.72% |
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |